The Record — theasbaghirecord.com. A filing is not a verdict. Nothing on this site is a finding of liability.

File 01

Who is Hooman Asbaghi

Hooman Ali Asbaghi. Named inventor on issued United States patents for safety catheters and needle guards. Plaintiff in Asbaghi vs Asbaghi, San Diego Superior Court, 25CU01380C.

This page is the person. It is not a finding of liability.

Patents

Safety needles and catheters. Each number is a public grant. The file is at Patents.

Documented: US 5,688,241 — Automatic non-reusable needle guard — 18 November 1997
US 6,379,336 — Protective device for injection or aspiration needle — 30 April 2002
US 8,216,188 — Safety catheter — 10 July 2012
US 8,747,361 — Safety catheter — 10 June 2014 — Milaghi Medical, Inc.
He is named as inventor on the face of each grant. A grant is not a product sitting on a hospital shelf.

Origin · 1990–2010

Early life and medical work

What he describes, what the documents show, and what remains unconfirmed.

Palmaz-Schatz and Bernard Valeix

His account: In the early 1990s he moved cardiovascular technology into Iran, working with Johnson & Johnson. The device was the Palmaz-Schatz stent. He worked with Dr Bernard Valeix. He says Valeix visited Iran in that period, treated patients at Imam Khomeini Medical Center, and trained cardiologists. He says Massoud Ghasemi came out of that training.
Documented: The Palmaz-Schatz device is a real Cordis / Johnson & Johnson coronary stent. The Food and Drug Administration announced approval of the balloon-expandable stent on 2 August 1994; the approval notice is in the Federal Register. Valeix is a French interventional cardiologist. His public listing as a cardiologist in Marseille is Marseille listing. He is a named author of a 1995 multicenter study on intracoronary stenting. Massoud Ghasemi later lists Valeix among his references.
Unconfirmed: A public record of those Iran visits, a case log, or a Johnson & Johnson transfer file in Asbaghi’s name. This page does not treat the introduction of the stent as a finding.

Athens, October 1994

His account: In 1994 he arranged for Massoud Ghasemi to attend a biomedical conference in Athens.
Documented: The Third World Bio-Medical Conference of the Hellenic Diaspora was held in Athens on 21–23 October 1994. That date is printed on the preliminary programme in this file.
Unconfirmed: Asbaghi or Massoud Ghasemi on that programme. A ticket or registration in either name. A conference existing is not proof they were in the hall.

Padtan Elm, 1995

His account: He co-founded Padtan Elm in Tehran in the mid-1990s.
Documented: The company’s archived About page printed founded in 1995. The share split and later gazettes live on What is Padtan Elm. The 1999 power of attorney is its own room.
Unconfirmed: The signed founding register, and the exact first share split.

United States measures, 1995

His account: As a United States citizen, the 1995 restrictions on trade with Iran narrowed the work he could do there and preceded his return to San Diego in 1999.
Documented: On 6 May 1995 President Clinton issued Executive Order 12959, effective 7 May 1995, prohibiting most United States exports of goods, technology, and services to Iran. The order is public. It does not name Asbaghi, Padtan Elm, or a stent.
Unconfirmed: A document that the order was the reason for his return.

Trans In’Tech, 1996

His account: While Padtan Elm and the Madaen laboratory were being built, Farideh Kavesh asked that Ommid Asbaghi help with the United States side. He says he agreed, and that Ommid and Carolin Botzenhardt were to handle American transfers so he could stay on the Iran work. He says that arrangement was first called Ayla Medical. He says that within months Ommid and Carolin were at odds, that Carolin told him Ommid had opened another company — Trans In’Tech — to work around him, and that Ommid confirmed it. He says Kavesh knew and supported the new company.
Documented: Trans In’Tech, LLC was filed in California on 12 July 1996, state document 199619410017. Public dumps that cite the California Secretary of State name Ommid Asbaghi and Farideh Kavesh on that company. A directory still prints scientific research, medical research, and diagnostic equipment. The same two names appear on the network chart in this file.
Unconfirmed: A California filing for Ayla Medical in those years. This search did not find one. A document that Trans In’Tech was created to bypass him. A document that Kavesh directed it. Whether the later public status is Active or Inactive — the dumps do not agree.

Madaen and Biotech — claimed 1997, on paper 2002

His account: He founded Biotech Ltd in 1990 and, with Massoud Ghasemi, established a catheterization laboratory at Madaen in 1997.
Documented: A signed instrument dated 5 Shahrivar 1381 (27 August 2002) names Eng. Hooman Asbaghi and Dr Massoud Ghasemi among the board, with Biotech Company and Madaen Hospital Company as representatives. The face is financial statements approved that day. It does not print a founding year. He dates the laboratory to 1997; that certificate is not this page.
Unconfirmed: 1990 articles for Biotech, or a 1997 founding certificate for the laboratory.

Return, 1999

His account: In 1999 he returned to San Diego to work on his own devices. Before leaving Tehran he gave Farideh Kavesh the 1999 power of attorney — document 10808702/97, Third Notary Office, no. 198 — covering shares, property, contracts, banks, and votes at Padtan Elm.
Documented: Executive Order 12959 is the May 1995 public order. The patents that follow 1999 are public. The 1999 power of attorney is its own window. The first page is on this file.
Unconfirmed: That the 1995 order was the sole reason he left.

Scripps Clinic, 2003

His account: He later arranged advanced training for Massoud Ghasemi at Scripps Clinic in La Jolla under Dr Paul Teirstein in 2003 and Dr Mohsin Saeed thereafter.
Documented: Massoud Ghasemi’s curriculum vitae lists a 2003 certification in endovascular intervention at Scripps Clinic, California. Under references he names Valeix in France, Saeed as head of vascular radiology at Scripps Clinic, and Teirstein as head of cardiology at Scripps Clinic. Teirstein and Saeed are physicians on the Scripps staff. Asbaghi’s name does not appear on that curriculum vitae. The full eight-page document is on Massoud Ghasemi. The public biography page is not always reachable. The Scripps names on this page are training and references. They are not a finding about a hip implant.
Unconfirmed: A letter placing Asbaghi as the person who secured the training.

United States work, 2002–2010

His account

After the return he took leadership roles as president of H.B.A. Medical Group, worked with MedPro Safety Products, and developed the safety-syringe and blood-collection devices that Visual Connections later sold.

Documented

Trade press in those years names him as the inventor of MedPro’s passive blood-collection devices and as the owner of Visual Connections, the California company that sold MedPro the underlying designs. Issued patents in this stretch include US 6,379,336 (30 April 2002) and US 6,869,415 (22 March 2005), assigned to Vacumate, LLC, Lexington.

Lexington Herald-Leader, 9 March 2009. Today’s Medical Developments, 16 March 2009, “Designing to Prevent Needlestick Injuries.”

Medical Device Daily, 29 September 2009. MedPro entered an exclusive agreement with Advanced MedTech, “wholly owned by Hooman Asbgahi, the inventor of MedPro’s phlebotomy products, marketed by Greiner Bio-One under its Vacuette brand as the Vacuette Premium Safety Needle System and Vacuette Premium Blood Collection Set.” The misspelling is in the quotation. MedPro took a first right of refusal on intellectual property in which he had an interest.

BioSpace, 13 January 2010. Pharmaceutical Business Review / BioSpace, January 2010.

Unconfirmed

That he sat as a director of MedPro. The releases call him inventor, owner of Visual Connections, and exclusive design consultant. The $5 million catheter price was contingent on financing and design criteria; this page does not write that he was paid $5 million.

United States companies

The names are different paper. They are not collapsed here.

H.B.A. Medical Group, Inc.

His account

After 1999 he led H.B.A. Medical Group.

Documented

The Nevada officer listing names Hooman Asbaghi as President and as Director of H.B.A. MEDICAL GROUP, INC., PO BOX 70477, Las Vegas, NV 89170.

US 6,530,905, Self-sheathing dental needle, 11 March 2003, inventor Hooman A. Asbaghi, assignee HBA Medical Group, Inc. See the HBA Medical Group assignee record. The Nydegger file already names Hooman Asbaghi and HBA Medical Group Inc. as plaintiffs.

Unconfirmed

That the Nevada entity is still active on the day this page is read. A person-index row is not a current good-standing printout.

Milaghi / Millaghi Medical, Inc.

Documented: On Patents: US 8,747,361, Safety catheter, 10 June 2014, inventors Don Millerd and Hooman Asbaghi, assignee Milaghi Medical, Inc. US 8,216,187, Safety catheter, 10 July 2012, inventors Don Millerd and Hooman A. Asbaghi, assignee Millaghi Medical, Inc. The inventor record prints both grants.
Unconfirmed: That Milaghi and Millaghi are the same charter. Both spellings are printed as the grants print them. They are not merged into one finding here.

MMI, LLC

Documented

Later applications name applicant MMI, LLC and inventor Hooman Asbaghi / Hooman A. Asbaghi, including US 2020/0237278 and US 2022/0039712. See the MMI, LLC assignee record.

MMI, LLC on LinkedIn describes a San Diego medical-device design firm founded in 2017. The heading on his LinkedIn profile prints MMI MEDICAL.

This MMI, LLC is not MMI Medical Group, Inc. of Los Angeles, and it is not Medical Microinstruments, the Italian robotics company.

Unconfirmed

Directory revenue and headcount.

Advanced MedTech / Advanced Medical Technologies, Inc.

Documented

Medical Device Daily, 29 September 2009 reports MedPro’s exclusive agreement with Advanced MedTech. The article states AMT “is wholly owned by Hooman Asbgahi” and that he is the inventor of MedPro’s phlebotomy products marketed by Greiner Bio-One as Vacuette Premium. The misspelling is in the quotation.

A directory listing prints Advanced Medical Technologies, Inc., principal Hooman Asbaghi, 2500 6th Ave Unit 1008, San Diego, CA 92103-6636, founded 2012, filing number C3231930. The same street appears on MMI, LLC directory lines. That is an address overlap, not a finding the two charters are one company.

Unconfirmed

Directory revenue and headcount.

Nipro

His account: After he returned to San Diego he licensed safety-needle work to Nipro, and he has described that license as about $1 million.
Documented: Nipro sells safety needles under the SafeTouch name. That is a public product line. On the pages checked for this file, it does not print his name as licensor. The Nydegger file prints that negligent office procedures led to loss of the client’s patent protection. US 6,530,905 is the HBA grant in this file.
Unconfirmed: That a major company walked after that grant lapsed. That the company was Nipro. That $1 million changed hands.